Article
Perfusion‐Based Production of rAAV via an Intensified Transient Transfection Process
18 Mar 2025
Abstract excerpt
Increasing demand for recombinant adeno-associated virus (rAAV)-based gene therapies necessitates increased manufacturing production. Transient transfection of mammalian cells remains the most commonly used method to produce clinical-grade rAAVs due to its ease of implementation. However, transient transfection processes are often characterized by suboptimal yields and low fractions of full-to-total capsids, both...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
